Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)
Phibro Animal Health (PAHC) posted Non-Current Deferred Tax Liability of $8.8 million for Q1 2022, up 9.72% on a QoQ basis from $8.1 million in Q4 2021, and down 28.45% year-over-year from $12.4 million in Q1 2021.
Analysis
Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022) Analysis & Trends
Phibro Animal Health has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $8.8 million in Q1 2022.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 28.45% year-over-year to $8.8 million in Q1 2022; TTM through Mar 2022 was $8.8 million, a 28.45% decrease from a year earlier, with the FY2021 full-year figure at $6.6 million, down 43.1% from the prior year.
- Non-Current Deferred Tax Liability was $8.8 million for Q1 2022 at Phibro Animal Health, up from $8.1 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $12.4 million in Q1 2021, with the low at $6.6 million in Q2 2021.
- Average Non-Current Deferred Tax Liability over 4 years is $9.4 million, with a median of $9.0 million recorded in 2019.
- The largest YoY upside for Non-Current Deferred Tax Liability was 33.1% in 2021 against a maximum downside of 43.1% in 2021.
- Over 4 years, Non-Current Deferred Tax Liability stood at $9.5 million in 2019, then grew by 26.6% to $12.1 million in 2020, then tumbled by 33.09% to $8.1 million in 2021, then advanced by 9.72% to $8.8 million in 2022.
- The last three Non-Current Deferred Tax Liability figures came in at $8.8 million (Q1 2022), $8.1 million (Q4 2021), and $7.3 million (Q3 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Mar 31, 2021 | 12.37 Mn |
| Dec 31, 2020 | 12.05 Mn |
| Jun 30, 2020 | 11.68 Mn |
| Mar 31, 2020 | 9.29 Mn |
| Dec 31, 2019 | 9.52 Mn |
| Sep 30, 2019 | 9.02 Mn |
| Jun 30, 2019 | 8.98 Mn |